Candy-immunomodulator

 

(57) Abstract:

The invention relates to medicine, namely General medicine and dentistry. Candy-immunomodulator of carbohydrates, the odorant and the base further comprises a dry powder spleen pigs, citric acid, and water, used as a base food gelatin, as odorants - food essence, and as carbohydrates sorbitol and molasses, components are taken in certain proportions. Candy-immunomodulator improves the immune status of the person, increases the resistance of the organs and tissues of the body, it is prophylactic respiratory and inflammatory diseases. table 2.

The invention relates to medicine, in particular to General medicine and dentistry.

There is a method of treatment of purulent and burn wounds on patent N 2016577, Russia, class A 61 K 35/28, which consists in applying to the wound surface solution reopoligliukina, pre perfoirmance through xenogenesis.

The disadvantage of this method is that perfuziruemye through xenogenesis solution cannot be used orally to improve the immune status of the organism, because the contents gelugor reopoligliukina, perfoirmance through xenogenesis, and intravenous drip can give an allergic reaction.

Famous chewing gum.with. N 1806738, class A 61 K 9/68) that contains carbohydrates, calcium salts, ethyl alcohol and beeswax.

Famous chewing gum, taken as a prototype, has only seriesproduction properties and does not have a strong effect improve the immune status of the person.

The invention consists in that candy-immunomodulator containing carbohydrates, the odorant and the base further comprises a dry powder spleen pigs, citric acid, and water, used as a base food gelatin, as odorants - food essence, and as carbohydrates sorbitol and molasses, in the following ratio, wt.%:

The dry powder of the spleen - 2-3

Gelatin - 16-20

Sorbitol - 45-50

Syrup - 10-12

Citric acid - 1,5-2

Food essence - 0,1-0,2

Water - the rest

Declare candy-immunomodulator, including natural immunogen (powder spleen pigs and food gelatin), increases the immune status of the person, is used for the prevention of colds in the fall and in the alawneh of various etiologies. In addition, chewing the candy enhances the secretion of saliva helps cleanse the teeth from the soft plaque. Increased microcrystallization, the enzymatic activity of saliva and bactericidal activity of epithelial cells.

Candy-immunomodulator is made as follows.

In capacity fall asleep gelatin, pour boiled water at room temperature in the amount of 9/10 of the total volume of water required in the recipe, and leave to swell for at least 1 h Capacity with swollen gelatin incubated in a water bath at a temperature not exceeding 70oC until the gelatin has dissolved. In the cooking apparatus pour water in the amount of 1/10 of the required in the recipe. When hashing enter sorbitol, bring to a boil, enter the syrup, powder spleen, bring to a boil and boil for 1-2 minutes Then injected a solution of gelatin, citric acid, and aromatic essences. The candy mass is stirred for 5-6 min and poured into molds, stamped in starch. Spill the candy mass are within no more than 30 minutes Then the candy out of the starch and placed on the baking sheets for natural drying. Drying is carried out at a temperature of not more than 30oC for 10 h

the I of the retina, focal atopic dermatitis. Received as pathogenetically therapy data candies, already after 5 days, the day of neuralgic pain stopped, two nights in a row were briefly characterized neuralgic pain and itching on the thumbs and right legs. Spontaneous bleeding from the gums stopped bleeding gums occurs only during brushing.

Welcome 2 candy 3 times a day for 30 days has eliminated neuralgic pain, bleeding gums (carried out sanitation of the oral cavity, see table. 1, laboratory results).

In the analysis of blood and saliva from 03.04.95,, 17.04.95,, 03.05.95, in the dynamics of the observed increase in the concentration of sLgA phagocytosing activity of neutrophils, the tendency to increase of T-lymphocytes.

In example 2, you can lead a comparative indicators of dental and immune status of children from 3 to 6 years before and after chewing candy-immunomodulator (PL. 2).

Candy-immunomodulator containing carbohydrates, a perfume and a base, characterized in that it further comprises a dry powder spleen pigs, citric acid, and water, used as a base food gelatin, as odorants - Piwik dry spleen - 2,0 - 3,0

Gelatin - 16,0 - 20,0

Sorbitol - 45,0 - 50,0

Syrup - 10,0 - 12,0

Citric acid - 1,5 - 2,0

Food essence - 0,1 - 0,2

Water - The Rest

 

Same patents:

Chewing gum // 2029474
The invention relates to food industry, namely the production of chewing gum, and may find use as therapeutic agents aimed at preventing violations of and normalization of carbohydrate and lipid metabolism

Chewing gum // 2022555
The invention relates to medicine is approved for prevention and treatment of dental caries and solves the problem of creating treatment and prevention of chewing gum with increased prolongation of the introduction of fluoride in the oral cavity, high cleaning effect and shelf life
The invention relates to medicine and can be used to produce chewing gum HEALTH-5"

The invention relates to medicine, namely to methods for preparations from bone marrow, in particular negative regulators of hemopoiesis
The invention relates to medicine, in particular for surgical treatment of musculoskeletal system
The invention relates to medicine, namely the creation of an organ-specific homeopathic drugs for stimulation of myeloid and lymphoid blood sprouts
Solution: bone // 2055535
The invention relates to medicine, namely to traumatology and orthopedics, dental surgery, and can be used in the treatment of patients with lesions of bone

The invention relates to the production of the drugs used in medical practice, and relates to a method of obtaining domestic product, similar to the mechanism of biological action of the drug "Cerebrolysin" firm Ebewe, Austria
The invention relates to the production of the drugs used in medical practice, and relates to a method of obtaining domestic product, similar to the mechanism of biological action of the drug "Cerebrolysin" company Ebewe, Austria

The invention relates to medicine, in particular, to a method for immunomodulator of mielopid

The invention relates to the field of immunology, immunopharmacology and can be used in medicine, veterinary medicine, intensive care, intensive therapy

FIELD: medicine, surgery, transplantology.

SUBSTANCE: embryonic spleen should be sampled, washed in nutritive medium № 199 to be placed into fresh medium № 199 to obtain homogenate in teflon homogenizer followed by centrifuging; then one should isolate the upper, medium and inferior layers, suck off medium layer and the upper part of inferior layer; the cell mixture obtained should be diluted in nutritive medium № 199 to be then introduced by injections into mesentery of small intestine or rectus muscle of abdomen. The present innovation favors the activation of immune system in patients undergone splenectomic operation and in those in case of surgical immunodefficient state due to high functional and regenerating activity of transferred embryonic splenic cells.

EFFECT: higher efficiency of prophylaxis.

6 dwg, 2 tbl

FIELD: medicine.

SUBSTANCE: method involves using mononuclear autologic marrow fraction containing 6-9x104 mesenchyma cells per 1 ml or autologic mesenchyma trunk cells. The cells are separated from brain bioptate in the amount of 106 cells/kg of patient body mass. The preparations are intracoronarily introduced in fractions at a rate of 3-5 ml/min into the right coronary artery. The introduction is also carried out in intra-arterial mode in jets or in drops.

EFFECT: higher survival rate and life quality of cardiologic patients.

1 dwg

FIELD: medicine.

SUBSTANCE: method involves introducing autologic mesenchyma trunk cells as a single intravenous drop dose or in the amount of 1 mln cells per 1 kg of patient body weight.

EFFECT: provided stable clinical remission.

FIELD: medicine, surgery.

SUBSTANCE: method involves every day covering a wound with an agent comprising of pig spleen homogenate and oxygenated with perfluorane taken in the following amounts: 100 g of pig spleen homogenate and 10 ml of oxygenated perfluorane. Invention promotes to accelerating sanitation of suppurative wounds due to activation of topical immunity and activation of regenerating processes. Invention can be used in treatment of suppurative wounds.

EFFECT: improved treatment method of wounds.

2 ex

FIELD: medicine, oncourology.

SUBSTANCE: the present innovation deals with treating locally spread tumor diseases of urinary bladder due to applying either chemo- and/or radiation therapy. Moreover, one should intravenously once inject by drops autologous mesenchymal stem cells (AMSC) at the quantity of 1 mln cells/kg patient's body weight. Moreover, in case of chemotherapy AMSC should be injected during the period before the 20-th d after the last injection of chemopreparation, in case of radiation therapy - 12-15 d against the day of irradiation. In case of chemoradiation therapy AMSC should be injected after chemotherapy before the course of radiation therapy. This method enables to carry out chemoradiation therapy in patients with severe accompanying diseases that prevent such a therapy, and prevent the development of general toxic complications of chemoradiation therapy and medicinal and radiation-caused cystitis.

EFFECT: higher efficiency of therapy.

3 ex, 2 tbl

Up!